Page last updated: 2024-09-02

fingolimod hydrochloride and Gastrointestinal Stromal Neoplasm

fingolimod hydrochloride has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dumont, AG; Reynoso, DG; Trent, JC1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Gastrointestinal Stromal Neoplasm

ArticleYear
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers -- Letter.
    Cancer research, 2011, Mar-15, Volume: 71, Issue:6

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Fingolimod Hydrochloride; Gastrointestinal Stromal Tumors; Humans; Immunosuppressive Agents; Inhibitory Concentration 50; Mice; Mutation; Propylene Glycols; Protein Phosphatase 2; Proto-Oncogene Proteins c-kit; Sphingosine

2011